Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population

被引:19
|
作者
Bello-Lepe, Sebastian [1 ,2 ]
Francisca Alonso-Sanchez, Maria [1 ,2 ,3 ]
Ortega, Alonso [1 ,2 ,3 ]
Gaete, Marcelo [4 ]
Veliz, Marcela [4 ]
Lira, Juan [5 ]
Perez Salas, Claudia Paz [5 ]
机构
[1] Univ Valparaiso, Fac Med, Escuela Fonoaudiol, Vina Del Mar, Chile
[2] UCL, Psychol & Language Sci Div, London, England
[3] Univ Valparaiso, Fac Med, Ctr Invest Desarrollo Cognic & Lenguaje, CIDCL UV, Angamos 655, Vina Del Mar 2540064, Chile
[4] Univ Arturo Prat, Escuela Psicol, Iquique, Chile
[5] Univ Concepcion, Fac Ciencias Sociales, Dept Psicol, Concepcion, Chile
关键词
Montreal Cognitive Assessment; Mini-Mental State Examination; Mild cognitive impairment; Dementia; Cognitive screening test; Clinical neuropsychology; MINI-MENTAL-STATE; ALZHEIMERS ASSOCIATION WORKGROUPS; ASSESSMENT MOCA; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; EXAMINATION MMSE; IMPAIRMENT; DEMENTIA; RECOMMENDATIONS; DISEASE;
D O I
10.1159/000506280
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The Montreal Cognitive Assessment (MoCA) is a sensitive screening instrument for mild neurocognitive disorder (mild NCD). However, cut-off scores and accuracy indices should be established using representative samples of the population. In this context, the aim of this study was to update the normative values, and diagnostic efficiency statistics of the MoCA to detect mild NCD in the Chilean population. Methods: This study included 226 participants from the north, center, and south of the country, classified into 3 groups: healthy elderly (HE; n = 113), mild NCD (n = 65), and major neurocognitive disorder (major NCD; n = 48). Results: The optimal cut-off score to discriminate mild NCD from HE participants was 20 points with a sensitivity of 82.8% and a specificity of 84.1%. The observed balance between sensitivity and specificity shows a good test performance either to confirm or discard a diagnosis. The cut-off between mild NCD and major NCD from HE participants was 19 points with 85.6% of sensitivity and 90.3% of specificity. Conclusion: Overall diagnostic accuracy can be considered as outstanding (AUC =0.904) when discriminating HE from both mild NCD and major NCD. These results showed that the MoCA is a suitable tool to identify mild NCD and major NCD. (c) 2020 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:105 / 114
页数:10
相关论文
共 50 条
  • [41] Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the Montreal Cognitive Assessment
    Fujiwara, Yoshinori
    Suzuki, Hiroyuki
    Yasunaga, Masashi
    Sugiyama, Mika
    Ijuin, Mutsuo
    Sakuma, Naoko
    Inagaki, Hiroki
    Iwasa, Hajime
    Ura, Chiaki
    Yatomi, Naomi
    Ishii, Kenji
    Tokumaru, Aya M.
    Homma, Akira
    Nasreddine, Ziad
    Shinkai, Shoji
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2010, 10 (03) : 225 - 232
  • [42] Screening an elderly hearing impaired population for mild cognitive impairment using Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA)
    Lim, Magdalene Yeok Leng
    Loo, Jenny Hooi Yin
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (07) : 972 - 979
  • [43] Detection of Major and Mild Neurocognitive Disorder with the Verbal Naming Test
    Spalding-Wilson, Kelsey
    Harris, Grant
    Windham, Victoria A.
    Strutt, Adriana M.
    Yochim, Brian P.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2022, 28 (07) : 700 - 708
  • [44] Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia
    Yang, Zixu
    Rashid, Nur Amirah Abdul
    Quek, Yue Feng
    Lam, Max
    See, Yuen Mei
    Maniam, Yogeswary
    Dauwels, Justin
    Tan, Bhing Leet
    Lee, Jimmy
    SCHIZOPHRENIA RESEARCH, 2018, 199 : 58 - 63
  • [45] Benefits of Cognitive Treatments Administered to Patients Affected by Mild Cognitive Impairment/Mild Neurocognitive Disorder
    Cavallo, Marco
    Signorino, Arianna
    Perucchini, Maria Luisa
    DRUG DEVELOPMENT RESEARCH, 2016, 77 (08) : 444 - 452
  • [46] Group intensive rehabilitation in patients with major and mild neurocognitive disorder
    Panerai, S.
    Tasca, D.
    Musso, S.
    Catania, V.
    Ruggeri, F.
    Raggi, A.
    Muratore, S.
    Prestianni, G.
    Bonforte, C.
    Ferri, R.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 52 : S89 - S90
  • [47] Montreal Cognitive Assessment in the Elderly Croatian Population
    Boban, M.
    Martinez, I.
    Zuna, P. Crnac
    Jurilj, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 444 - 444
  • [48] Screening for neuropsychological assessment in the diagnostics of neurocognitive disorder
    Ramakers, Inez H. G. B.
    Verhey, Frans R. J.
    INTERNATIONAL PSYCHOGERIATRICS, 2022, 34 (06) : 519 - 521
  • [49] Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease
    Lucza, Tivadar
    Karadi, Kazmer
    Kallai, Janos
    Weintraut, Rita
    Janszky, Jozsef
    Makkos, Attila
    Komoly, Samuel
    Kovacs, Norbert
    BEHAVIOURAL NEUROLOGY, 2015, 2015
  • [50] Exploring the Utility of the Montreal Cognitive Assessment to Detect HIV-Associated Neurocognitive Disorder: The Challenge and Need for Culturally Valid Screening Tests in South Africa
    Robbins, Reuben N.
    Joska, John A.
    Thomas, Kevin G. F.
    Stein, Dan J.
    Linda, Teboho
    Mellins, Claude A.
    Remien, Robert H.
    CLINICAL NEUROPSYCHOLOGIST, 2013, 27 (03) : 437 - 454